UBS GROUP AG-REG (UBS) Stock News
NYSE:UBS - New York Stock Exchange, Inc. - CH0244767585 - Common Stock - Currency: USD
UBS Latest News, Press Relases and Analysis
Will the Stock Market Crash or Soar in the Second Half of 2025? Wall Street Analysts Are Changing Their Answers.
Several Wall Street analysts have upwardly revised their year-end targets for the S&P 500 in recent weeks.
Cerberus and Dean Metropoulos also made a bid for WK Kellogg, sources say
-Private equity firm Cerberus Capital Management, which owns a stake in grocer Albertsons, and billionaire investor Dean Metropoulos teamed up in an unsuccessful bid for cereal maker WK Kellogg, according to three sources familiar with the matter. The consortium, which was being advised by investment banks UBS and Macquarie Capital, ultimately lost out to private, family-owned Ferrero Group, which on Thursday announced an agreement to acquire WK Kellogg for around $3.1 billion.
Mid-Cap Banks' Loan Growth May Exceed Expectations, UBS Says
US mid-cap banks' loan growth could surprise to the upside beginning in the second quarter, driven b
UBS raises global oil refining margins outlook amid delays and closures
UBS announced a revised outlook on the global oil refining industry, anticipating a significant tightening of supply balances.
The S&P 500 is starting to close its 2025 gap to foreign stocks as Trump leans in to tariff fights
The S&P 500 is outperforming some major international funds in July after lagging in the first half.
Mentions: GS
Vertiv Stock Rebounds After Overreaction To AWS News
Vertiv stock rose Friday after plunging Thursday on a report that AWS had developed a possible competing liquid-cooling system.
UBS likes these high-quality stocks — and they pay dividends
UBS uses quantitative models and fundamental analysis to determine which stocks pay dividends and are also high quality. Here are some names that made the cut.
1 Warren Buffett Stock That Could Go Parabolic in 2025 and Beyond
Many investors have soured on this former market darling, but that may be a "go" sign for new buyers in light of its quiet and underappreciated progress on the AI front.
Trump's 200% tariff threat leaves pharma firms scrambling with scenario planning
A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.
UBS Trims Price Target but Stays Bullish on United Therapeutics (UTHR)
United Therapeutics Corp. (NASDAQ:UTHR) is one of the 11 best debt-free stocks to invest in right now. The company boasts a strong portfolio led by Tyvaso, its inhaled therapy for pulmonary hypertension, and a growing pipeline targeting pulmonary arterial hypertension (PAH). Its existing therapies are leading to stronger topline and earnings growth; the 17% year-over-year growth […]
Mentions: UTHR
UBS Reiterates Buy on Deckers (DECK) as HOKA Momentum Powers Growth Outlook
Deckers Outdoor Corp. (NYSE:DECK) is one of the 11 best debt-free stocks to invest in right now. The company presents a strong investment case driven by its consistent revenue growth, expanding global footprint, and disciplined execution. In FY 2025, the company reported balanced performance across its major brands, UGG and HOKA, which now contribute 51% and […]
Mentions: DECK
Waller Says Fed Is Too Tight, Can Consider July Rate Cut
Federal Reserve Governor Christopher Waller says the Fed should look through the price impact of tariffs during an event hosted by the Dallas Fed. (Source: Bloomberg)
Why Elon Musk’s Third Party Plans Face Big Hurdles
Elon Musk wants to create his own political party, but it's not as easy as typing out a post and hitting send. Here are the potential hurdles the America Party might face. (Source: Bloomberg)
Mentions: NVDA
Top-Performing E-Commerce Stock MercadoLibre Falls As Trump Pledges 50% Brazil Tariffs
MercadoLibre stock was down more than 3% in Thursday trading after Trump threatened a 50% tariff on Brazil, MercadoLibre's largest market.
AI Capex Buildup Not Going Anywhere: UBS's Hoffmann-Burchardi
Stocks have room to rise despite tariff-induced volatility, says Ulrike Hoffmann-Burchardi, UBS Global Wealth CIO Americas and Global Head of Equities, on Open Interest. (Source: Bloomberg)
UBS Lowers United Natural Foods (UNFI) PT, Keeps Neutral Rating
United Natural Foods, Inc. (NYSE:UNFI) is one of the 11 Best Food Stocks to Buy According to Wall Street Analysts. On June 11, UBS lowered its price target on United Natural Foods, Inc. (NYSE:UNFI) from $30 to $26 and kept its “Neutral” rating. This decision came after United Natural Foods, Inc. (NYSE:UNFI) reported its third […]
Mentions: UNFI
UBS Keeps Buy Rating on McDonald’s (MCD), Sees Growth Potential
McDonald’s Corporation (NYSE:MCD) is one of the 11 Best Food Stocks to Buy According to Wall Street Analysts. On June 27, UBS reiterated its “Buy” rating for McDonald’s Corporation (NYSE:MCD) with a price target of $350. McDonald’s Corporation (NYSE:MCD) experienced a decline since May 19, which the firm sees as creating an attractive entry point […]
Mentions: MCD
UBS Keeps Buy Rating on Domino’s Pizza (DPZ)
Domino’s Pizza, Inc. (NASDAQ:DPZ) is one of the 11 Best Food Stocks to Buy According to Wall Street Analysts. On May 27, UBS maintained its “Buy” rating for Domino’s Pizza, Inc. (NASDAQ:DPZ) with a price target of $540. The analysts at UBS are confident that the company has strong potential to increase sales momentum in […]
Mentions: DPZ
UBS Maintains a Buy on Genmab (GMAB) With a DKK2,500 PT
Genmab A/S (NASDAQ:GMAB) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. On June 25, UBS analyst Xian Deng maintained a Buy rating on Genmab A/S (NASDAQ:GMAB) and set a price target of DKK2,500.00. The company reported $715 million in revenue for the first three months of 2025 compared to $603 million […]
UBS Reiterates a Buy Rating on Acadia Healthcare (ACHC) With a $45 Price Target
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is one of the 13 Cheap Healthcare Stocks with Huge Upside Potential. In a report released on June 23, A.J. Rice from UBS reiterated a Buy rating on Acadia Healthcare Company, Inc. (NASDAQ:ACHC) with a price target of $45.00. The company’s fiscal Q1 2025 results showed a revenue of $770.5 […]
The AI gold rush is here, but adoption data shows that its just getting started
The adoption of artificial intelligence tools is increasing at a rapid pace but remains far from ubiquity.
Trump's latest tariff shock just hit one of the best-performing stock markets in the world
The latest escalation in trade tensions comes as this stock market is enjoying a strong year.
UBS CEO Sees 'Fantastic Opportunity' In US Despite Short-Term Tariff Uncertainty, Suggests Secular Trends Remain 'Intact'
In a recent interview, UBS Group AG CEO Sergio Ermotti expressed optimism about the U.S. market, despite ongoing tariff uncertainties.
UBS Japan Global Markets Co-Head Kuroda Is Exiting Bank
UBS Group AG’s Japan global markets co-head Naohiro Kuroda is leaving the bank, people with knowledge of the matter said, months after the veteran of structured investments business touted his team’s expansion.
Banks Start Pitching $4.25 Billion in Debt for Boots Buyout
Wall Street banks including JPMorgan Chase & Co. and UBS Group AG have begun early pricing discussions with investors for a $4.25 billion debt package to help finance Sycamore Partners’ buyout of UK pharmacy Boots, according to people familiar with the matter.
Mentions: JPM
GE Vernova (GEV) Stock Soars on AI Energy Boom—UBS Targets $614
GE Vernova Inc. (NYSE:GEV) is one of the 10 AI Stocks Investors Are Watching This Week. On July 8, UBS initiated coverage of the stock with a “Buy” rating and $614 price target. According to the firm, the wind turbine maker is set to grow backed by booming electricity demand from data centers and a limited supply […]
Mentions: GEV
CoreWeave (CRWV) Makes $9 Billion Bet on Core Scientific to Power AI Growth
CoreWeave, Inc. (NASDAQ:CRWV) is one of the 10 AI Stocks Investors Are Watching This Week. On July 7, CoreWeave announced that it will buy crypto miner Core Scientific in an all-stock deal valued at about $9 billion. The deal comes amid AI infrastructure firms racing to secure the energy and data center capacity needed for powering burgeoning […]
Exxon's Results to Show Impact of Weak Energy Prices, Refining Margins, UBS Says
Exxon Mobil's (XOM) second-quarter earnings are expected to reflect the impact of energy price decli
Mentions: XOM
Recursion Pharmaceuticals (RXRX) Rallies 8.7% on Hypophosphatasia
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of These 10 Stocks Are Making Big Moves. Recursion Pharmaceuticals bounced back by 8.72 percent on Tuesday to close at $5.36 apiece following news that it acquired a $25-million interest in REV102—an ENPP1 inhibitor in preclinical development for the treatment of hypophosphatasia. In a statement on Tuesday, Rallybio said it […]